본문으로 건너뛰기
← 뒤로

B-cell acute lymphoblastic leukemia following myelodysplastic syndromes: a case report and literature review.

증례보고 1/5 보강
Journal of hematopathology 2026 Vol.19(1) p. 3
Retraction 확인
출처

Ding H, Feng W, Luo H, Jin J

📝 환자 설명용 한 줄

Myelodysplastic syndromes (MDS) comprise clonal hematopoietic stem cell disorders characterized by heterogeneous clinical manifestations.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Ding H, Feng W, et al. (2026). B-cell acute lymphoblastic leukemia following myelodysplastic syndromes: a case report and literature review.. Journal of hematopathology, 19(1), 3. https://doi.org/10.1007/s12308-026-00680-y
MLA Ding H, et al.. "B-cell acute lymphoblastic leukemia following myelodysplastic syndromes: a case report and literature review.." Journal of hematopathology, vol. 19, no. 1, 2026, pp. 3.
PMID 41636965 ↗

Abstract

Myelodysplastic syndromes (MDS) comprise clonal hematopoietic stem cell disorders characterized by heterogeneous clinical manifestations. Approximately 20-30% of MDS cases progress to acute myeloid leukemia, whereas transformation to acute lymphoblastic leukemia (ALL) is extremely rare. In this report, we present the case of a Chinese male patient who presented with MDS-refractory anemia with ringed sideroblasts, which developed into B-cell ALL. During disease transformation, the patient acquired novel gene mutations. By comparing the gene mutations identified at the initial MDS diagnosis with those observed at the time of transformation to ALL, we aim to elucidate the genetic alterations associated with disease progression. Furthermore, we provide a comprehensive review of 60 MDS and MDS/MPN cases reported in the literature so far.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반